NJ stamping company holding joint patents with Raytheon
The company is not named and no financial detail is published. What follows is what the owner wanted, what the process ran into, and how it resolved.
What happened
We were asked to provide a valuation of this stamping company two years before it sold. The owner, a brilliant manufacturing mind with a thriving company, held joint patents with Raytheon. He had been diagnosed with a life-threatening disease. Like many entrepreneurs, he had his identity wrapped up in his work, so he chose to continue working.
His widow called for help after he passed. She was being bombarded with subpar offers and needed someone to step in and take over the negotiation process. The company was successfully sold to a private equity-backed strategic buyer after the founder's death, at a much higher price than they had previously offered.
Every closed engagement is described this way. The company is never named, and no figure that could identify it is published (except where permission is granted) — during the process or after it.
The NDA and teaser came down at completion of the transaction. What a seller is owed in confidence during a sale, they are owed afterward.
See all closed transactionsAccelerated represents lower-middle-market manufacturers pursuing a complete sale, recapitalization or partnership with a larger firm.
Discuss a confidential sale